Trial Profile
To evaluate the efficacy of Belimumab on B-cells in patients with Systemic Lupus Erythematosus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Belimumab (Primary) ; Glucocorticoids
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 29 Aug 2016 New trial record